Also in this section

2009

  • Guzman J. Adapting approval mechanisms to new NTD drugs. DNDi’s 2nd Stakeholders’ Meeting & 3rd African Meeting. Nairobi, Kenya, June, 2009.
  • Heeley E, Peiris D, Weekes A, Cass A, Anderson C, Patel A, Chalmers J. Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Sydney, Australia, August. Heart Lung and Circulation. 2009;18(Suppl 3):S280.
  • Heeley E, Peiris D, Weekes A, Morgan C, Cass A, Anderson C, Patel A, Chalmers J. Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Sydney, Australia, August. Heart Lung and Circulation. 2009;18(Suppl 3):S280.
  • Peiris D, Joshi R, Webster R, Groenestein P, Usherwood T, Heeley E, Turnbull F, Lipman A, Patel A. A Novel electronic decision support system to assist general practitioners in cardiovascular disease risk management - a pilot evaluation. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Sydney, Australia, August 2009. Heart Lung and Circulation. 2009;18(Suppl 3):S269.
  • Turnbull F, Arima H, Heeley E, Peiris D, Weekes A, Morgan C, Cass A, Anderson C, Patel A, Chalmers J. Cardiovascular risk management among female and male patients in Australian General Practice: the AusHEART study. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Sydney, Australia, August. Heart Lung and Circulation. 2009;8(Suppl 3):S272.